References

  1. Amar L, Lepoutre C, Bobrie G, Plouin PF. Hypertension artérielle endocrine. Rev Med Interne. 2010;23(3):697-704. PubMed | Google Scholar

  2. Steichen O, Plouin PF. Prise en charge actuelle de l'hypertension artérielle. Rev Med Interne. 2013; Volume 35(Issue 4):Pages 235-242. PubMed | Google Scholar

  3. Maria Czarina Acelajado, David Calhoun A. Resistant hypertension, secondary hypertension, and hypertensive Crises: diagnostic evaluation and treatment. Cardiol Clin. 2010;28(4):639-654. PubMed | Google Scholar

  4. Amar L, Lorthioir A , Giavarini A, Plouin P, Azizi M. Hypertension artérielle d'origine surrénale : reconnaître, évaluer et prendre en charge. Presse Med. 2014;43(4):420-427. PubMed | Google Scholar

  5. Sukor N. Endocrine hypertension - Current understanding and comprehensive management review. Eur J Intern Med. 2011;22(5):433-440. PubMed | Google Scholar

  6. Al-Salameh A, Cohen R, Chanson P, Plouin PF. Données récentes sur l'hypertension endocrine. Ann Endocrinol. 2012;73 (S2): 26-35. PubMed | Google Scholar

  7. Amar J. Quand et comment recherché une cause surrénalienne à une hypertension artérielle? Réalités Cardiologiques. 301Mai/Juin 2014. PubMed | Google Scholar

  8. Paul Stewart M. Endocrine hypertension. MEDICINE. 2013;41:9. PubMed | Google Scholar

  9. Plouin PF. Prevalence and etiologies of endocrine hypertension. Best Practice & Research Clinical Endocrinology & Metabolism. 2006;20(3):vii- viii. PubMed | Google Scholar

  10. Rory Mc Quillan F, Peter Conlon J. Secondary Hypertension. National Kidney Foundation Primer on Kidney Diseases 6th Revised edition. Google Scholar

  11. Viera AJ, Neutze DM. Diagnosis of secondary hypertension: an age-based approach. Am Fam Physician. 2010;82(12):1471-1478. PubMed | Google Scholar

  12. Beltran S, Borson-Chazot F. Phéochromocytome. Emc Endocrinologie - Nutrition Doi : 10.1016/S1155-1941(13)64274-2. PubMed | Google Scholar

  13. Zuber SM, Kantorovich V, Pacak K. Hypertension in Pheochromocytoma: Characteristics and Treatment. Endocrinol Metab Clin North Am. 2011;40(2): 295-311. PubMed | Google Scholar

  14. Fountoulakis S, Tsatsoulis A. Molecular genetics aspects and pathophysiology of endocrine hypertension. Hormones. 2006;5(2);90:106. PubMed | Google Scholar

  15. Luca F et al. Manifestations cardiaques des phéochromocytomes. Ann Endocrinol. 2009;70(1):43-47. PubMed | Google Scholar

  16. Pogorzelski R. The effect of surgical treatment of pheochromocytoma on concomitant arterial hypertension and diabetes mellitus in a single-centre retrospective study. Cent European J Urol. 2014;67(4):361-365. PubMed | Google Scholar

  17. Vesin C. Hypertensions artérielles secondaires d'origine surrénalienne: syndromes de Conn, de Cushing et autres entités. EMC Cardiologie. 2009:1-12 [Article 11-301-F-10]. PubMed | Google Scholar

  18. LeRoith D. Endocrine hypertension. Endocrinol Metab Clin N Am. 2011;40(2):xiii-xv. PubMed | Google Scholar

  19. Trifanescu R et al. Screening for Secondary Endocrine Hypertension in Young Patients. MAEDICA - a Journal of Clinical Medicine. 2013;8(2):108-115. PubMed | Google Scholar

  20. Christian Koch A. Endocrine hypertension: What is new? Rev Port Endocrinol Diabetes Metab. 2012;7(2):52-61. PubMed | Google Scholar

  21. David Weiner I. Endocrine and Hypertensive Disorders of Potassium Regulation: primary aldosteronism. Seminars in Nephrology. 2013;l33(3):265-276. PubMed | Google Scholar

  22. Maria Abad- Cardiel et al. Hypertension Caused by Primary Hyperaldosteronism: increased heart damage and cardiovascular risk. Rev Esp Cardiol. 2013;66(1):47-52. PubMed | Google Scholar

  23. Fedrizzi D et al. Hypertension-related factors in patients with active and inactive acromegaly. Arq Bras Endocrinol Metab. 2011; 55(7): 468-474. PubMed | Google Scholar

  24. Omura M. Prospective Study on the Prevalence of Secondary Hypertension among Hypertensive Patients Visiting a General Outpatient Clinic in Japan Hypertens Res. NCBI. 2004;27(3) 193-202. PubMed | Google Scholar